Contact Getein

Anti-CCP Fast Test Kit (lmmunofluorescence Assay)

  • Anti-CCP Fast Test Kit (lmmunofluorescence Assay)
  • Anti-CCP Fast Test Kit (lmmunofluorescence Assay)

Anti-CCP Fast Test Kit

(lmmunofluorescence Assay)

 

Intended Use

Anti-CCP Fast Test Kit (lmmunofluorescence Assay) is intended for in vitro quantitative determination of anti-CCP in serum, plasma or whole blood samples. The test is designed to aid in the diagnosis of autoimmune diseases, such as rheumatoid arthritis (RA).

 

About Anti-CCP

Anti-CCP is an autoantibody that synthesizes cyclic citrullinepolypeptide (CCP) as antigens. Anti-CCP mainly consists of lgG and it can be used for the early diagnosis of RA due to its high sensitivity and specificity to the disease. Currently, it is believed that the sensitivity of Anti-CCP to RA diagnosis is 50%-78% with a specificity of 96%. The positive rate of early RA patients is 80%. Meanwhile, radiological examination results show that patients with positive Anti-CCP have significantly more severe joint injuries than those with negative Anti-CCP. Therefore, Anti-CCP as a prognostic indicator can play an important role in monitoring the development and progression of rheumatoid arthritis disease. In addition, Anti-CCP is a sensitive indicator for differentiating invasive and non-invasive RA.

 

Specification

 

Test Item Sample Type Method Storage Condition
Anti-CCP S/P/WB Immunofluorescence Assay 4-30°C
Detection Range  Test Time Cut-off Value Shelf Life
10.0-400.0 U/mL 15 min 25.0 U/mL 24 months

 

 

Applicable Device

Getein 1100 Immunofluorescence Quantitative Analyzer

Getein 1180 Immunofluorescence Quantitative Analyzer

Getein 1600 Immunofluorescence Quantitative Analyzer

 

Leave your message here should you be interested by any of our product offerings, we will get back to you in minimal delay.

Leave A Message

Leave A Message
Leave your message here should you be interested by any of our product offerings, we will get back to you in minimal delay.

Home

Products

contact

service